{
  "compound": "CBD",
  "condition": "PARKINSONS",
  "effect_size": "Large (d = 1.12)",
  "study_type": "RCT",
  "source": "NORML:PD_RCT_006",
  "participants": "6 PD patients with psychosis",
  "year": 2008,
  "notes": "CBD for Psychosis in Parkinson's Disease: Randomized Trial",
  "confidence": "medium",
  "abstract": "BPRS: Significant reduction (p<0.05); PPQ: Significant reduction (p<0.05); Psychotic symptoms reduced without motor worsening"
}